SCOPE FLUIDICS SA ZY-10

Research SCOPE FLUIDICS SA ZY-10 (S84) on Bullrun: market cap EUR 88.26M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerS84
• ExchangeF
• CountryPoland
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyEUR
• Market capEUR 88.26M
• Financial periodFY2023
• RevenuePLN 516.00K
• Revenue growth27.7%
• Net income-PLN 18.79M

Valuation Snapshot

latest market cap is EUR 88.26M.

About SCOPE FLUIDICS SA ZY-10

Scope Fluidics S.A., a biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. The company offers BacterOMIC, an antibiotic susceptibility testing. Scope Fluidics S.A. was founded in 2010 and is based in Warsaw, Poland.

Frequently asked questions

What is SCOPE FLUIDICS SA ZY-10's market cap?

SCOPE FLUIDICS SA ZY-10's market capitalization is EUR 88.26M.

What does SCOPE FLUIDICS SA ZY-10 do?

Scope Fluidics S.A., a biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. The company offers BacterOMIC, an antibiotic susceptibility testing. Scope Fluidics S.A. was founded in 2010 and is based in Warsaw, Poland.